Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 6
1964 4
1965 1
1966 1
1967 4
1968 7
1969 10
1970 9
1971 8
1972 8
1973 12
1974 9
1975 13
1976 6
1977 4
1978 5
1979 7
1980 3
1981 5
1982 8
1983 3
1984 5
1985 13
1986 8
1987 14
1988 16
1989 11
1990 23
1991 15
1992 31
1993 23
1994 26
1995 21
1996 24
1997 19
1998 21
1999 27
2000 22
2001 21
2002 37
2003 49
2004 61
2005 36
2006 33
2007 31
2008 28
2009 25
2010 26
2011 29
2012 31
2013 35
2014 29
2015 45
2016 24
2017 31
2018 37
2019 24
2020 27
2021 38
2022 60
2023 61
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

343 results

Results by year

Filters applied: Meta-Analysis, Review, Systematic Review, in the last 10 years. Clear all
Page 1
The Life Cycle of the Vaccinia Virus Genome.
Greseth MD, Traktman P. Greseth MD, et al. Annu Rev Virol. 2022 Sep 29;9(1):239-259. doi: 10.1146/annurev-virology-091919-104752. Epub 2022 May 18. Annu Rev Virol. 2022. PMID: 35584888 Free article. Review.
Poxviruses, of which vaccinia virus is the prototype, are a large family of double-stranded DNA viruses that replicate exclusively in the cytoplasm of infected cells. ...
Poxviruses, of which vaccinia virus is the prototype, are a large family of double-stranded DNA viruses that replicate exclusively in …
Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics.
Guo ZS, Lu B, Guo Z, Giehl E, Feist M, Dai E, Liu W, Storkus WJ, He Y, Liu Z, Bartlett DL. Guo ZS, et al. J Immunother Cancer. 2019 Jan 9;7(1):6. doi: 10.1186/s40425-018-0495-7. J Immunother Cancer. 2019. PMID: 30626434 Free PMC article. Review.
Cancer vaccines and oncolytic immunotherapy are promising treatment strategies with potential to provide greater clinical benefit to patients with advanced-stage cancer. In particular, recombinant vaccinia viruses (VV) hold great promise as interventional agents. ...
Cancer vaccines and oncolytic immunotherapy are promising treatment strategies with potential to provide greater clinical benefit to patient …
Vaccinia virus-based vector against infectious diseases and tumors.
Zhang Z, Dong L, Zhao C, Zheng P, Zhang X, Xu J. Zhang Z, et al. Hum Vaccin Immunother. 2021 Jun 3;17(6):1578-1585. doi: 10.1080/21645515.2020.1840887. Epub 2021 Feb 19. Hum Vaccin Immunother. 2021. PMID: 33606578 Free PMC article. Review.
Vaccinia virus was used to prevent smallpox. After the World Health Organization declared smallpox extinct, vaccinia virus has been explored for the development of vaccines against a variety of infectious diseases. ...Here we provide a brief review of the history, c …
Vaccinia virus was used to prevent smallpox. After the World Health Organization declared smallpox extinct, vaccinia virus has …
Modified Vaccinia Virus Ankara: History, Value in Basic Research, and Current Perspectives for Vaccine Development.
Volz A, Sutter G. Volz A, et al. Adv Virus Res. 2017;97:187-243. doi: 10.1016/bs.aivir.2016.07.001. Epub 2016 Aug 1. Adv Virus Res. 2017. PMID: 28057259 Free PMC article. Review.
Safety tested Modified Vaccinia virus Ankara (MVA) is licensed as third-generation vaccine against smallpox and serves as a potent vector system for development of new candidate vaccines against infectious diseases and cancer. Historically, MVA was developed by serial tiss …
Safety tested Modified Vaccinia virus Ankara (MVA) is licensed as third-generation vaccine against smallpox and serves as a potent ve …
Vaccinia-based vaccines to biothreat and emerging viruses.
Nagata LP, Irwin CR, Hu WG, Evans DH. Nagata LP, et al. Biotechnol Genet Eng Rev. 2018 Apr;34(1):107-121. doi: 10.1080/02648725.2018.1471643. Epub 2018 May 21. Biotechnol Genet Eng Rev. 2018. PMID: 29779454 Free PMC article. Review.
Vaccinia has recently been modified for use as an oncolytic treatment for cancer therapy. ...This article reviews the development of a universal vaccinia vaccine platform for emerging diseases or biothreat agents, based on nonreplicating or live attenuated vaccin …
Vaccinia has recently been modified for use as an oncolytic treatment for cancer therapy. ...This article reviews the development of …
Oncolytic Vaccinia Virus in Lung Cancer Vaccines.
Truong CS, Yoo SY. Truong CS, et al. Vaccines (Basel). 2022 Feb 4;10(2):240. doi: 10.3390/vaccines10020240. Vaccines (Basel). 2022. PMID: 35214699 Free PMC article. Review.
Therapeutic cancer vaccines represent a promising therapeutic modality via the induction of long-term immune response and reduction in adverse effects by specifically targeting tumor-associated antigens. Oncolytic virus, especially vaccinia virus (VV) is a promising cancer …
Therapeutic cancer vaccines represent a promising therapeutic modality via the induction of long-term immune response and reduction in adver …
Oncolytic vaccinia virus and cancer immunotherapy.
Xu L, Sun H, Lemoine NR, Xuan Y, Wang P. Xu L, et al. Front Immunol. 2024 Jan 12;14:1324744. doi: 10.3389/fimmu.2023.1324744. eCollection 2023. Front Immunol. 2024. PMID: 38283361 Free PMC article. Review.
Despite achieving positive results in cellular and organismal studies, there are currently only a few approved oncolytic viruses for clinical use. Vaccinia virus (VACV) has emerged as a potential candidate due to its ability to infect a wide range of cancer cells. ...
Despite achieving positive results in cellular and organismal studies, there are currently only a few approved oncolytic viruses for clinica …
Vaccinia virus evasion of regulated cell death.
Veyer DL, Carrara G, Maluquer de Motes C, Smith GL. Veyer DL, et al. Immunol Lett. 2017 Jun;186:68-80. doi: 10.1016/j.imlet.2017.03.015. Epub 2017 Mar 31. Immunol Lett. 2017. PMID: 28366525 Free article. Review.
The biological importance of regulated cell death is illustrated by the rich repertoire of host signalling cascades causing cell death and by the multiple strategies exhibited by viruses to block death signal transduction and preserve cell viability. Vaccinia virus (VACV), …
The biological importance of regulated cell death is illustrated by the rich repertoire of host signalling cascades causing cell death and b …
Vaccinia Virus Activation and Antagonism of Cytosolic DNA Sensing.
El-Jesr M, Teir M, Maluquer de Motes C. El-Jesr M, et al. Front Immunol. 2020 Oct 1;11:568412. doi: 10.3389/fimmu.2020.568412. eCollection 2020. Front Immunol. 2020. PMID: 33117352 Free PMC article. Review.
Recognition of cytosolic DNA has become a central immune sensing mechanism involved in infection, autoinflammation, and cancer immunotherapy. Vaccinia virus (VACV) is the prototypic member of the family Poxviridae and the vaccine used to eradicate smallpox. ...
Recognition of cytosolic DNA has become a central immune sensing mechanism involved in infection, autoinflammation, and cancer immunotherapy …
Bovine Vaccinia: Insights into the Disease in Cattle.
Matos ACD, Rehfeld IS, Guedes MIMC, Lobato ZIP. Matos ACD, et al. Viruses. 2018 Mar 9;10(3):120. doi: 10.3390/v10030120. Viruses. 2018. PMID: 29522489 Free PMC article. Review.
Bovine vaccinia (BV), caused by Vaccinia virus (VACV), is a zoonosis characterized by exanthematous lesions in the teats of dairy cows and the hands of milkers and is an important public health issue. ...
Bovine vaccinia (BV), caused by Vaccinia virus (VACV), is a zoonosis characterized by exanthematous lesions in the teats of da …
343 results